Single-Agent Immunosuppression After Liver Transplantation
- 1 January 2002
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 62 (11) , 1587-1597
- https://doi.org/10.2165/00003495-200262110-00002
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Orthotopic liver transplantation using low-dose tacrolimus and sirolimusLiver Transplantation, 2001
- Use of daclizumab as initial immunosuppression in liver transplant recipients with impaired renal functionLiver Transplantation, 2001
- Early cyclosporine monotherapy in liver transplantation: A 5-year follow-up of a prospective, randomized trialHepatology, 1998
- Defining the outcome of immunosuppression withdrawal after liver transplantationHepatology, 1998
- TEN YEARS OF LIVER TRANSPLANTATIONTransplantation, 1997
- A RANDOMIZED PROSPECTIVE TRIAL OF STEROID WITHDRAWAL AFTER LIVER TRANSPLANTATION1,2Transplantation, 1995
- Corticosteroid withdrawal after liver transplantationSurgery, 1995
- Acute cellular rejection after liver transplantation: Variability, morbidity, and mortalityLiver Transplantation and Surgery, 1995
- STEROID WITHDRAWAL FROM LONG-TERM IMMUNOSUPPRESSION IN LIVER ALLOGRAFT RECIPIENTSTransplantation, 1993
- Corticosteroids stimulate hepatitis B virus DNA, mRNA and protein production in a stable expression systemJournal of Hepatology, 1990